Acquisitions4 Jun 2025, 01:18 pm
Caplin Point Laboratories Acquires Triwin Pharma S.A DE C.V, Mexico for $1 Mexican Peso Per Share
AI Summary
Caplin Point Laboratories Limited, a Chennai-based pharmaceutical company, announced that its wholly owned subsidiary, Caplin Point Far East Limited, Hong Kong, has executed a Share Purchase Agreement dated June 03, 2025, to acquire the entire stake in Triwin Pharma S.A DE C.V, a Mexican company, for $1 Mexican Peso per share. The acquisition is aimed at expanding Caplin Point's presence in the Mexican market and supporting the establishment of a stock-and-sale model.
Key Highlights
- Caplin Point Laboratories Limited's wholly owned subsidiary, Caplin Point Far East Limited, Hong Kong, has agreed to acquire Triwin Pharma S.A DE C.V, a Mexican company, for $1 Mexican Peso per share.
- The acquisition is aimed at expanding Caplin Point's presence in the Mexican market and supporting the establishment of a stock-and-sale model.
- Triwin Pharma S.A DE C.V was incorporated on 12th February, 2019, and it has reported no turnover in the past three years.
- The acquisition is a strategic decision, as it provides a local partner in Mexico, enabling participation in government tenders.
- The acquisition is expected to be completed within 30 days from the date of signing the Share Purchase Agreement (SPA).